Effects of Gum Arabic Supplementation in Hemodialysis Patients
Parole chiave
Astratto
Date
Ultimo verificato: | 11/30/2018 |
Primo inviato: | 12/26/2018 |
Iscrizione stimata inviata: | 12/26/2018 |
Primo pubblicato: | 12/30/2018 |
Ultimo aggiornamento inviato: | 12/30/2018 |
Ultimo aggiornamento pubblicato: | 01/02/2019 |
Data di inizio effettiva dello studio: | 10/31/2018 |
Data di completamento primaria stimata: | 02/28/2019 |
Data stimata di completamento dello studio: | 05/31/2019 |
Condizione o malattia
Intervento / trattamento
Dietary Supplement: Gum Arabic
Other: B
Fase
Gruppi di braccia
Braccio | Intervento / trattamento |
---|---|
Experimental: A Patients will receive 10 g of Gum Arabic supplementation daily for four weeks. Gum Arabic is provided in the form of easily soluble granules. Participants are asked to dissolve it in water or juice and drink it. | |
Placebo Comparator: B Patients will receive 5 g of maltodextrin supplementation daily for four weeks. Maltodextrin is an easily digested polysacharide provided in the form of soluble whitish powder that has no taste or odor. Participants are asked to dissolve it in water or juice and drink it. | Other: B Maltodextrin powder, easily soluble |
Experimental: C Patients will receive 20 g of Gum Arabic supplementation daily for four weeks | |
Experimental: D Patients will receive 40 g of Gum Arabic supplementation daily for four weeks |
Criteri di idoneità
Età idonea per lo studio | 18 Years Per 18 Years |
Sessi idonei allo studio | All |
Accetta volontari sani | sì |
Criteri | Inclusion Criteria: - Adult end-stage renal disease patients maintained on regular hemodialysis Exclusion Criteria: - Chronic liver disease - Malignant condition - Inflammatory bowel disease - History of bowel resection - Long term antibiotic therapy - Pregnancy or lactation - Current use of immunosuppressive medication |
Risultato
Misure di esito primarie
1. Highly sensitive C-reactive protein (hs CRP) level [4 weeks]
2. Total anti-oxidant capacity [4 weeks]
3. Blood urea level [4 weeks]
Misure di esito secondarie
1. Serum calcium [4 weeks]
2. Serum phosphorus [4 weeks]
3. Serum uric acid [4 weeks]